'But Alzheimer's Disease Disrupts Renewal Process' ...
The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in ...
Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
The Hoskinson Government and Policy Center proudly supports the Stem Cell Freedom Act, a bill expanding access to life-saving stem cell treatments ...
Adults whose brains still have strong neuron production seem to have better memory and cognitive function than do those in ...
Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases ...
Many people’s brains deteriorate as they age, becoming riddled with malfunctioning proteins that result in cell death and the ...
Scientists have built a massive cellular atlas showing how aging reshapes the body across 21 organs. Studying nearly 7 million cells, they found that aging starts earlier than expected and unfolds in ...
Researchers used single-nucleus RNA sequencing and chromatin accessibility profiling to map human hippocampal neurogenesis across adulthood, aging, and Alzheimer’s disease. They found that chromatin ...
GLP-1 drugs have captured global attention, but they come with limitations - tolerability issues, muscle mass loss, and ...
Increasing doses of laromestrocel are associated with decreases in soluble (degraded) tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE-2), the cognate receptor for ...
The CL1 is the first commercial system from the same researchers who wowed the tech world in 2022 by teaching a cluster of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results